Each year, thousands of patients will undergo reconstructive surgery after cancer and trauma. These surgeries have the power to restore patients’ lives, yet too often they result in failure because there is no adequate device to monitor the patient after surgery. Hospitals are currently paying thousands of dollars per patient for inadequate monitoring technology. High false positive rates and low sensitivity has caused surgeons to demand a better device.
The EchoSure system is the first monitor to solve this need. By detecting complications earlier and with greater confidence, surgeons can fix the problem before it is too late. The EchoSure system is a novel approach to using ultrasound to monitor flaps and transplants. Color-duplex ultrasound has been proven as the ideal technology for this application yet has never been used clinically because it requires a highly skilled ultrasound technician to perform the monitoring. The EchoSure system combines a novel bio-absorbable echogenic marker with an ultrasound software package to deskill the process of ultrasound monitoring. What has previously required an expert in ultrasound technology can now be performed by a nurse at the bedside. Large animal trials have demonstrated the efficacy of EchoSure and usability studies suggest that the system will see rapid clinical adoption. Team EchoSure is dedicated to carrying this technology through to market. The EchoSure system has the power to prevent thousands of surgical failures, avoid unnecessary reoperations, and change lives. |
|